Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed Episode

NCT00191997 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Olanzapine

Sponsor

Eli Lilly and Company